Literature DB >> 18418552

Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Alexandros Theodoros Panagopoulos1, Carmen Lucia Penteado Lancellotti, José Carlos Esteves Veiga, Paulo Henrique Pires de Aguiar, Alison Colquhoun.   

Abstract

Most meningiomas are benign tumours of arachnoidal origin, although a small number have high proliferative rates and invasive properties which complicate complete surgical resection and are associated with increased recurrence rates. Few prognostic indicators exist for meningiomas and further research is necessary to identify factors that influence tumour invasion, oedema and recurrence. Paraffin sections from 25 intracranial meningiomas were analysed for expression of the proteins vascular endothelial growth factor (VEGF), VEGF receptors Flt1 and Flk1, E-cadherin, metalloproteinases 2 and 9 (MMP2, MMP9), CD44, receptor for hyaluronic acid-mediated motility (RHAMM), hyaluronic acid (HA), CD45, cyclooxygenase 2 (COX2), brain fatty acid binding protein (BFABP), Ki67, and proliferating cell nuclear antigen (PCNA). Correlations among protein expression were found for several markers of proliferation (Ki67, PCNA, MI) and microvessel density (MVD). COX2 expression increased with increasing with tumour grade and correlated with Ki67, PCNA, MI, MVD, and BFABP. BFABP expression also correlated with Ki67 and PCNA expression. Relationships were also identified among angiogenic factors (VEGF, Flt1, Flk1) and proliferation markers. Oedema was found to correlate with MMP9 expression and MMP9 also correlated with proliferation markers. No correlations were found for MMP2, E-cadherin, or CD44 in meningiomas. In conclusion Ki67, PCNA, MI, MVD, BFABP, and COX2 were significantly correlated with meningioma tumour grade and with each other. These findings, by correlating both intracellular fatty acid transport and eicosanoid metabolism with tumour proliferation, as determined by Ki67 labelling and mitotic index, suggest fatty acids are involved in the progression of meningiomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418552     DOI: 10.1007/s11060-008-9588-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  66 in total

Review 1.  Signaling properties of hyaluronan receptors.

Authors:  Eva A Turley; Paul W Noble; Lilly Y W Bourguignon
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

Review 2.  Molecular genetics of meningiomas.

Authors:  Brian T Ragel; Randy L Jensen
Journal:  Neurosurg Focus       Date:  2005-11-15       Impact factor: 4.047

3.  Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.

Authors:  Brian T Ragel; Randy L Jensen; David L Gillespie; Stephen M Prescott; William T Couldwell
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

4.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolfram Henn; Klaus D Zang; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

5.  Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

6.  Role of ischaemia in the genesis of oedema surrounding meningiomas assessed using magnetic resonance imaging and spectroscopy.

Authors:  Z Domingo; G Rowe; A M Blamire; T A Cadoux-Hudson
Journal:  Br J Neurosurg       Date:  1998-10       Impact factor: 1.596

7.  Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo.

Authors:  M H Deininger; M Weller; J Streffer; M Mittelbronn; R Meyermann
Journal:  Acta Neuropathol       Date:  1999-09       Impact factor: 17.088

8.  Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.

Authors:  L Palma; P Celli; C Franco; L Cervoni; G Cantore
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

9.  Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.

Authors:  Brian T Ragel; Randy L Jensen; David L Gillespie; Stephen M Prescott; William T Couldwell
Journal:  J Neurosurg       Date:  2005-09       Impact factor: 5.115

10.  Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape.

Authors:  Türker Kiliç; Yaşar Bayri; Koray Ozduman; Melih Acar; Semin Diren; Ozlem Kurtkaya; Gazanfer Ekinci; Kuyaş Buğra; Aydin Sav; M Memet Ozek; M Necmettin Pamir
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

View more
  15 in total

1.  CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma.

Authors:  Dexuan Ma; Ying Wang; Guhong Du; Jingyun Yang; Qisheng Tang; Liangfu Zhou
Journal:  Tumour Biol       Date:  2015-10-14

2.  Fatty acid synthase is a predictive marker for aggressiveness in meningiomas.

Authors:  Keishi Makino; Hideo Nakamura; Taku-ichiro Hide; Shigetoshi Yano; Jun-Ichiro Kuroda; Ken-Ichi Iyama; Jun-Ichi Kuratsu
Journal:  J Neurooncol       Date:  2012-06-29       Impact factor: 4.130

3.  Immunohistochemical characterization of brain-invasive meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Magnus B Arnli; Kathrin Torseth; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?

Authors:  V Barresi; E Vitarelli; G Tuccari; G Barresi
Journal:  J Neurooncol       Date:  2010-07-21       Impact factor: 4.130

5.  Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma.

Authors:  Patricia Guevara; Elizabeth Escobar-Arriaga; David Saavedra-Perez; Abelardo Martinez-Rumayor; Diana Flores-Estrada; Daniel Rembao; Alejandra Calderon; Julio Sotelo; Oscar Arrieta
Journal:  J Neurooncol       Date:  2009-12-15       Impact factor: 4.130

6.  Genetic and protein changes of E-cadherin in meningiomas.

Authors:  Nives Pećina-Slaus; Tamara Nikuseva Martić; Adam Jakov Deak; Martina Zeljko; Reno Hrasćan; Davor Tomas; Vesna Musani
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-12       Impact factor: 4.553

7.  CD44 Expression in Meningioma and its Correlation with Proliferation Indices.

Authors:  Rasha Ramadan Mostafa; Rasha Ahmed Khairy
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 8.  Metastasis of lung adenosquamous carcinoma to meningioma: case report with literature review.

Authors:  Ryan Glass; Supriya R Hukku; Bruce Gershenhorn; Juan Alzate; Bradford Tan
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

9.  Proteins involved in regulating bone invasion in skull base meningiomas.

Authors:  Fateme Salehi; Shahrzad Jalali; Ryan Alkins; Joon-Il Lee; Shelly Lwu; Kelly Burrell; Fred Gentili; Sidney Croul; Gelareh Zadeh
Journal:  Acta Neurochir (Wien)       Date:  2012-12-13       Impact factor: 2.216

10.  Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.

Authors:  Quan Huang; Song-Li Zhao; Xiao-Ying Tian; Bin Li; Zhi Li
Journal:  Int J Med Sci       Date:  2013-01-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.